# Goldman Sachs Group Inc: overview

GS · NYSE · CIK 886982 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gs.md) · [Financials](/companies/gs/financials.md) · [Filings](/companies/gs/filings.md) · [Insiders](/companies/gs/insiders.md)

Latest reported revenue: [$20.34bn](/filings/0000886982-26-000297.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 3, 2026 (XBRL us-gaap:RevenuesNetOfInterestExpense, accession 0000886982-26-000297).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [12.7](/filings/0000886982-25-001411.md) | [13.9 d](/filings/0000886982-26-000091.md) | [15.1](/filings/0000886982-26-000118.md) | [14.6](/filings/0000886982-26-000297.md) | [15.2](/filings/0000886982-25-001411.md) | [13.5 d](/filings/0000886982-26-000091.md) | [17.2](/filings/0000886982-26-000118.md) | [20.3](/filings/0000886982-26-000297.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [23.5%](/filings/0000886982-25-001411.md) | [29.6% d](/filings/0000886982-26-000091.md) | [31.5%](/filings/0000886982-26-000118.md) | [25.5%](/filings/0000886982-26-000297.md) | [27.0%](/filings/0000886982-25-001411.md) | [34.3% d](/filings/0000886982-26-000091.md) | [32.7%](/filings/0000886982-26-000118.md) | [32.6%](/filings/0000886982-26-000297.md) |
| Diluted EPS | $ per share | [8.40](/filings/0000886982-25-001411.md) | not reported | [14.12](/filings/0000886982-26-000118.md) | [10.91](/filings/0000886982-26-000297.md) | [12.25](/filings/0000886982-25-001411.md) | not reported | [17.55](/filings/0000886982-26-000118.md) | [20.98](/filings/0000886982-26-000297.md) |
| Free cash flow | $bn | [(38.5) d](/filings/0000886982-25-001411.md) | [46.2 d](/filings/0000886982-26-000091.md) | [(37.7)](/filings/0000886982-26-000118.md) | [5.2 d](/filings/0000886982-26-000297.md) | [2.1 d](/filings/0000886982-25-001411.md) | [(16.8) d](/filings/0000886982-26-000091.md) | [(32.4)](/filings/0000886982-26-000118.md) | [5.6 d](/filings/0000886982-26-000297.md) |

- Revenue. XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [59.3](/filings/0000886982-24-000006.md) | [47.4](/filings/0000886982-25-000005.md) | [46.3](/filings/0000886982-26-000091.md) | [53.5](/filings/0000886982-26-000091.md) | [58.3](/filings/0000886982-26-000091.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [36.5%](/filings/0000886982-24-000006.md) | [23.8%](/filings/0000886982-25-000005.md) | [18.4%](/filings/0000886982-26-000091.md) | [26.7%](/filings/0000886982-26-000091.md) | [29.5%](/filings/0000886982-26-000091.md) |
| Diluted EPS | $ per share | [59.45](/filings/0000886982-24-000006.md) | [30.06](/filings/0000886982-25-000005.md) | [22.87](/filings/0000886982-26-000091.md) | [40.54](/filings/0000886982-26-000091.md) | [51.32](/filings/0000886982-26-000091.md) |
| Free cash flow | $bn | [1.6](/filings/0000886982-24-000006.md) | [5.0](/filings/0000886982-25-000005.md) | [(14.9)](/filings/0000886982-26-000091.md) | [(15.3)](/filings/0000886982-26-000091.md) | [(47.2)](/filings/0000886982-26-000091.md) |

- Revenue. XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gs/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-28 | [Leslie Ericka T](/insiders/1910388.md) | Chief Administrative Officer, Officer | Sale (S) | 100 | $926.28 | $92.6k | [Form 4](/filings/0001910388-26-000015.md) |
| 2026-10-27 | [Leslie Ericka T](/insiders/1910388.md) | Chief Administrative Officer, Officer | Sale (S) | 58 | $912.23 | $52.9k | [Form 4](/filings/0001910388-26-000015.md) |
| 2026-10-27 | [Leslie Ericka T](/insiders/1910388.md) | Chief Administrative Officer, Officer | Sale (S) | 52 | $911.21 | $47.4k | [Form 4](/filings/0001910388-26-000015.md) |
| 2026-10-27 | [Leslie Ericka T](/insiders/1910388.md) | Chief Administrative Officer, Officer | Sale (S) | 40 | $909.63 | $36.4k | [Form 4](/filings/0001910388-26-000015.md) |
| 2026-10-27 | [Solomon David M](/insiders/1693709.md) | Chairman of the Board and CEO, Director, Officer | Sale (S) | 437 | $912.11 | $398.6k | [Form 4](/filings/0001693709-26-000011.md) |
| 2026-10-27 | [Solomon David M](/insiders/1693709.md) | Chairman of the Board and CEO, Director, Officer | Sale (S) | 2,382 | $911.49 | $2.2m | [Form 4](/filings/0001693709-26-000011.md) |
| 2026-10-27 | [Solomon David M](/insiders/1693709.md) | Chairman of the Board and CEO, Director, Officer | Sale (S) | 9,181 | $910.46 | $8.4m | [Form 4](/filings/0001693709-26-000011.md) |
| 2026-10-22 | [Leslie Ericka T](/insiders/1910388.md) | Chief Administrative Officer, Officer | Sale (S) | 67 | $890.85 | $59.7k | [Form 4](/filings/0001910388-26-000012.md) |
| 2026-10-22 | [Leslie Ericka T](/insiders/1910388.md) | Chief Administrative Officer, Officer | Sale (S) | 183 | $890.03 | $162.9k | [Form 4](/filings/0001910388-26-000012.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $24.17bn | 23,900,376 |  | Reduced −88,990 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $19.04bn | 18,830,464 |  | Reduced −424,594 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $18.64bn | 18,425,670 |  | Added +39,036 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $8.20bn | 8,039,070 |  | Added +823,608 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $7.30bn | 7,215,421 |  | Added +7,176 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $7.11bn | 7,030,974 |  | Added +214,375 |
| [Fisher Asset Management, LLC](/funds/850529.md) | 2026-06-30 | $7.04bn | 6,964,113 |  | Added +136,803 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $7.02bn | 6,948,585 |  | Reduced −166,248 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $6.76bn | 6,680,811 |  | Added +225,800 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $4.99bn | 4,933,800 | Call | Added +210,200 |

## Recent filings

[All more than 10,000 filings](/companies/gs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 07:32 ET | [8-K](/filings/0000886982-26-000529.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886982-26-000529 |
| 2026-08-11 | 16:50 ET | [8-K](/filings/0001193125-26-344912.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-344912 |
| 2026-08-03 | 17:24 ET | [10-Q](/filings/0000886982-26-000297.md) | Quarterly report, period 2026-06-30 | 0000886982-26-000297 |
| 2026-07-27 | 16:27 ET | [8-K](/filings/0001193125-26-318147.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-318147 |
| 2026-07-21 | 16:35 ET | [8-K](/filings/0001193125-26-310408.md) | 9.01 Financial statements and exhibits | 0001193125-26-310408 |
| 2026-07-20 | 08:07 ET | [8-K](/filings/0001193125-26-308384.md) | 8.01 Other events | 0001193125-26-308384 |
| 2026-07-14 | 07:30 ET | [8-K](/filings/0000886982-26-000294.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886982-26-000294 |
| 2026-06-24 | 16:28 ET | [8-K](/filings/0001193125-26-281123.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-281123 |
| 2026-06-03 | 16:43 ET | [8-K](/filings/0001193125-26-255626.md) | 9.01 Financial statements and exhibits | 0001193125-26-255626 |
| 2026-05-12 | 16:18 ET | [8-K](/filings/0001193125-26-219511.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-219511 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000886982-26-000091.md), filed Feb 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 886982
- Tickers: GS, GSCE, GS-PA, GS-PC, GS-PD
- Exchange: NYSE
- SIC code: 6211 Security Brokers, Dealers & Flotation Companies
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:50 ET. No prices; not investment advice.